HA: female GU Exam
Overview of the Female Genitourinary Exam
Focuses on normal anatomy, evidence-based exam techniques, documentation, and cervical cancer screening.
Anatomy Review
Vulva Anatomy:
Includes mons pubis, labia majora, labia minora, clitoris, perineum.
Hymen is normally patent and does not break during intercourse.
Important for it to be tested for patentcy in newborns.
Pelvic Floor Anatomy:
Comprises muscles including bladder, rectum, and vagina.
Muscular tension can impact patient symptoms.
Uterus and Cervix:
Cervix opening (os) varies based on childbirth history, affecting examination.
Glandular cells can be found at the squamocolumnar junction, which may vary across patients.
Evidence-Based Exam Techniques
Preparation:
Ensure patient comfort: ask permission, provide chaperone, explain the process, and allow for patient control.
Speculum Selection:
Use appropriate size/speculum type (Peterson vs. Graves) and warm the speculum for comfort.
Exam Steps:
Conduct an external examination, internal via speculum, and bimanual exam to assess various reproductive structures, including the cervix and uterus.
Rectovaginal exams are now not routinely part of physical exams unless indicated.
Documentation of Findings
External Examination:
Note inguinal lymphadenopathy, identify any abnormal lesions/discharge.
Bimanual Exam:
Document the size, shape, position, and tenderness of the uterus and any associated masses.
Cervical Cancer Screening Guidelines
Cervical Cancer Screening Goals:
Early detection of precancerous changes to prevent cervical cancer.
HPV and Pap Testing:
Routine Pap smears begin at age 21; HPV primary screening recommended at age 25.
Enhanced screening methods: Pap every 3 years or co-testing every 5 years for those 30+.
Risk Factors:
Includes immunosuppression, prior treatments, and synthetic estrogen exposure.
Cervical cancer screenings can cease at age 65 if previous results are normal.
HPV Vaccine Information
Gardasil 9:
Approved for ages 9-45, prevents various cancers including cervical, anal, and head/neck cancers.
Encourage vaccination in patients up to age 45; often covered by insurance.